| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $102.2M | +8.8% | -12.0% |
| Cost of Revenue | $78.2M | +16.0% | +5.2% |
| Gross Profit | $24.1M | -9.3% | -42.5% |
| R&D Expense | $10.7M | -6.3% | -21.9% |
| SG&A Expense | $10.1M | -30.7% | -19.0% |
| Operating Income | -$11.6M | -2.2% | -345.7% |
| Interest Expense | $7.6M | -5.7% | +163.3% |
| Pre-tax Income | -$13.2M | +37.8% | -508.3% |
| Income Tax | $573K | +21.7% | -17.6% |
| Net Income | -$13.8M | +36.5% | -642.8% |
| EPS (Basic) | -$0.11 | +38.9% | -466.7% |
| EPS (Diluted) | -$0.11 | +38.9% | -650.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41.3M | -34.8% | -34.0% |
| Accounts Receivable | $61.0M | +12.1% | -30.1% |
| Inventory | $151.0M | -2.9% | +1.4% |
| Current Assets | $292.4M | -3.7% | -10.3% |
| Total Assets | $448.0M | -1.9% | -6.3% |
| Current Liabilities | $199.4M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | -131.2% | — |
| Capital Expenditures | $4.9M | +158.9% | — |
| Investing Cash Flow | -$9.4M | -146.3% | — |
| Financing Cash Flow | -$757K | -59.4% | — |
| Free Cash Flow | -$8.7M | -185.0% | — |
| -1.0% |
| Long-term Debt | $135.9M | -3.1% | -22.6% |
| Total Liabilities | $394.6M | -0.1% | -8.3% |
| Stockholders' Equity | $53.4M | -13.7% | +11.5% |